Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
出版年份 2018 全文链接
标题
Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
作者
关键词
-
出版物
Cells
Volume 7, Issue 10, Pages 176
出版商
MDPI AG
发表日期
2018-10-23
DOI
10.3390/cells7100176
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A scaffold-hopping approach to discover potent, selective and efficacious inhibitors of NF-κB inducing kinase
- (2018) Nicole Blaquiere et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of the NFκB-signaling pathway in cancer
- (2018) Longzheng Xia et al. OncoTargets and Therapy
- The Prognostic Role of the Non-Canonical Nuclear Factor-Kappa B Pathway in Renal Cell Carcinoma Patients
- (2018) Joanne Lua et al. UROLOGIA INTERNATIONALIS
- High IKKα expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)-positive breast cancer
- (2017) Lindsay Bennett et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers
- (2017) Nahoum G. Anthony et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K)
- (2017) Georgette M. Castanedo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial
- (2017) Antonia K Roseweir et al. JNCI-Journal of the National Cancer Institute
- Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial
- (2017) Antonia K Roseweir et al. JNCI-Journal of the National Cancer Institute
- Importance of the alternative NF-κB activation pathway in inflammation-associated gastrointestinal carcinogenesis
- (2016) Yvette J. Merga et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- miR-23a promotes IKKα expression but suppresses ST7L expression to contribute to the malignancy of epithelial ovarian cancer cells
- (2016) Zhen Yang et al. BRITISH JOURNAL OF CANCER
- Chronic lymphocytic leukaemia
- (2016) Lydia Scarfò et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- NF-κB deregulation in splenic marginal zone lymphoma
- (2016) Valeria Spina et al. SEMINARS IN CANCER BIOLOGY
- Noncanonical NF-κB Signaling in Health and Disease
- (2016) Gökhan Cildir et al. TRENDS IN MOLECULAR MEDICINE
- PI3K/Akt promotes feedforward mTORC2 activation through IKKα
- (2016) Han C. Dan et al. Oncotarget
- LGR5 expression is controled by IKKα in basal cell carcinoma through activating STAT3 signaling pathway
- (2016) Jiantao Jia et al. Oncotarget
- Prognostic significance of RelB overexpression in non-small cell lung cancer patients
- (2016) Hualong Qin et al. Thoracic Cancer
- Structural Basis for the Activation of IKK1/α
- (2016) Smarajit Polley et al. Cell Reports
- NIK regulates MT1-MMP activity and promotes glioma cell invasion independently of the canonical NF-κB pathway
- (2016) C L Duran et al. Oncogenesis
- Downregulation of miR-518a-3p activates the NIK-dependent NF-κB pathway in colorectal cancer
- (2015) L.L. QU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
- (2015) Larry Mansouri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation
- (2015) Sinyi Kong et al. JOURNAL OF IMMUNOLOGY
- Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation
- (2015) Yinghui Li et al. NATURE CELL BIOLOGY
- BRAF-induced tumorigenesis is IKKα-dependent but NF-κB–independent
- (2015) Pol Margalef et al. Science Signaling
- Apigenin blocks IKKα activation and suppresses prostate cancer progression
- (2015) Sanjeev Shukla et al. Oncotarget
- An Oncogenic Role for Alternative NF-κB Signaling in DLBCL Revealed upon Deregulated BCL6 Expression
- (2015) Baochun Zhang et al. Cell Reports
- BRAF-induced tumorigenesis is IKKα-dependent but NF-κB–independent
- (2015) Pol Margalef et al. Science Signaling
- Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice
- (2015) Sanjeev Shukla et al. PLoS One
- IκB Kinases Modulate the Activity of the Androgen Receptor in Prostate Carcinoma Cell Lines
- (2015) Garima Jain et al. NEOPLASIA
- Kinetics of CLL cells in tissues and blood during therapy with the BTK inhibitor ibrutinib
- (2014) D. Wodarz et al. BLOOD
- Recurrent mutations refine prognosis in chronic lymphocytic leukemia
- (2014) P Baliakas et al. LEUKEMIA
- NOTCH1, SF3B1, BIRC3andTP53mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment
- (2014) Sabina Chiaretti et al. LEUKEMIA & LYMPHOMA
- Lymphotoxin β receptor activation promotes bladder cancer in a nuclear factor-κB-dependent manner
- (2014) MO SHEN et al. Molecular Medicine Reports
- AI-06 * NON-CANONICAL NF-kB SIGNALING DRIVES THE AGGRESSIVE INVASIVENESS OF GLIOBLASTOMA
- (2014) E. Cherry et al. NEURO-ONCOLOGY
- Non-conventional functions for NF-κB members: the dark side of NF-κB
- (2014) L Espinosa et al. ONCOGENE
- Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts
- (2014) M. Ammirante et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of p53 and Rb Links the Alternative NF-κB Pathway to EZH2 Expression and Cell Senescence
- (2014) Alessio Iannetti et al. PLoS Genetics
- NFκB regulates expression of Polo-like kinase 4
- (2013) Adeline Ledoux et al. CELL CYCLE
- An IKK -E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence
- (2013) M. Ammirante et al. GENES & DEVELOPMENT
- Crystal Structure of a Human IκB Kinase β Asymmetric Dimer
- (2013) Shenping Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Proteasome Inhibition by Bortezomib Increases IL-8 Expression in Androgen-Independent Prostate Cancer Cells: The Role of IKK
- (2013) S. Manna et al. JOURNAL OF IMMUNOLOGY
- The role of tumour–stromal interactions in modifying drug response: challenges and opportunities
- (2013) Douglas W. McMillin et al. NATURE REVIEWS DRUG DISCOVERY
- Deficiency of Innate and Acquired Immunity Caused by an IKBKB Mutation
- (2013) Ulrich Pannicke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Downregulation of TRAF2 Mediates NIK-Induced Pancreatic Cancer Cell Proliferation and Tumorigenicity
- (2013) Heike Döppler et al. PLoS One
- A Structural Basis for IκB Kinase 2 Activation Via Oligomerization-Dependent Trans Auto-Phosphorylation
- (2013) Smarajit Polley et al. PLOS BIOLOGY
- Characterization of the Inhibitor of KappaB Kinase (IKK) Complex in Granulosa Cell Tumors of the Ovary and Granulosa Cell Tumor-Derived Cell Lines
- (2013) Stacey Jamieson et al. Hormones & Cancer
- The noncanonical NF-κB pathway
- (2012) Shao-Cong Sun IMMUNOLOGICAL REVIEWS
- Understanding NIK Regulation from Its Structure
- (2012) Zhihua Tao et al. STRUCTURE
- The Crystal Structure of the Catalytic Domain of the NF-κB Inducing Kinase Reveals a Narrow but Flexible Active Site
- (2012) Gladys de Leon-Boenig et al. STRUCTURE
- A Truncated Form of IKKα Is Responsible for Specific Nuclear IKK Activity in Colorectal Cancer
- (2012) Pol Margalef et al. Cell Reports
- Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response
- (2011) S. Gardam et al. BLOOD
- Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
- (2011) D. Rossi et al. BLOOD
- Inhibitory kappa B kinases as targets for pharmacological regulation
- (2011) Carly Gamble et al. BRITISH JOURNAL OF PHARMACOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Non-canonical NF-κB signaling activation and regulation: principles and perspectives
- (2011) Bahram Razani et al. IMMUNOLOGICAL REVIEWS
- Analysis of the chronic lymphocytic leukemia coding genome: role ofNOTCH1mutational activation
- (2011) Giulia Fabbri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Crystal structure of inhibitor of κB kinase β
- (2011) Guozhou Xu et al. NATURE
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Inflammation meets cancer, with NF-κB as the matchmaker
- (2011) Yinon Ben-Neriah et al. NATURE IMMUNOLOGY
- Cleavage of NIK by the API2-MALT1 Fusion Oncoprotein Leads to Noncanonical NF- B Activation
- (2011) S. Rosebeck et al. SCIENCE
- BAG3 is required for IKKα nuclear translocation and emergence of castration resistant prostate cancer
- (2011) M Ammirante et al. Cell Death & Disease
- The lymph node microenvironment promotes B-cell receptor signaling, NF- B activation, and tumor proliferation in chronic lymphocytic leukemia
- (2010) Y. Herishanu et al. BLOOD
- Classical and/or alternative NF- B pathway activation in multiple myeloma
- (2010) Y. N. Demchenko et al. BLOOD
- Constitutive noncanonical NFκB signaling in pancreatic cancer cells
- (2010) Catherine E. Wharry et al. CANCER BIOLOGY & THERAPY
- NF-κB in the regulation of epithelial homeostasis and inflammation
- (2010) Andy Wullaert et al. CELL RESEARCH
- Non-canonical NF-κB signaling pathway
- (2010) Shao-Cong Sun CELL RESEARCH
- NF-κB inducing kinase: A key regulator in the immune system and in cancer
- (2010) Yee Mon Thu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
- (2010) Massimo Ammirante et al. NATURE
- Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression
- (2010) Hsiangling Teo et al. NATURE CELL BIOLOGY
- IKKα and IKKβ Each Function to Regulate NF-κB Activation in the TNF-Induced/Canonical Pathway
- (2010) Mazhar Adli et al. PLoS One
- Antigens in chronic lymphocytic leukemia—Implications for cell origin and leukemogenesis
- (2010) Anders Rosén et al. SEMINARS IN CANCER BIOLOGY
- NIK is involved in constitutive activation of the alternative NF-κB pathway and proliferation of pancreatic cancer cells
- (2009) Takashi Nishina et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Structural insights into IKKβ inhibition by natural products staurosporine and quercetin
- (2009) Carolina M. Avila et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors
- (2009) John Liddle et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Biologic sequelae of I B kinase (IKK) inhibition in multiple myeloma: therapeutic implications
- (2009) T. Hideshima et al. BLOOD
- A Novel, Highly Selective, Tight Binding I B Kinase-2 (IKK-2) Inhibitor: A Tool to Correlate IKK-2 Activity to the Fate and Functions of the Components of the Nuclear Factor- B Pathway in Arthritis-Relevant Cells and Animal Models
- (2009) G. Mbalaviele et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Notch-1 activates estrogen receptor-α-dependent transcription via IKKα in breast cancer cells
- (2009) L Hao et al. ONCOGENE
- Geldanamycin inhibits tyrosine phosphorylation-dependent NF-κB activation
- (2008) Julie Crèvecoeur et al. BIOCHEMICAL PHARMACOLOGY
- High-Affinity Interaction between IKKβ and NEMO
- (2008) Yu-Chih Lo et al. BIOCHEMISTRY
- The NF- B subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
- (2008) S. Hewamana et al. BLOOD
- Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
- (2008) E. Rosati et al. BLOOD
- Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches
- (2008) P. Rizzo et al. CANCER RESEARCH
- Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease
- (2008) Martin Perez-Andres et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of Human Immunodeficiency Virus Type 1 Replication by Blocking I B Kinase with Noraristeromycin
- (2008) K. Asamitsu et al. JOURNAL OF BIOCHEMISTRY
- Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery
- (2008) Arup K. Ghose et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling
- (2008) Sivakumar Vallabhapurapu et al. NATURE IMMUNOLOGY
- Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK
- (2008) Brian J Zarnegar et al. NATURE IMMUNOLOGY
- Is NF-κB a good target for cancer therapy? Hopes and pitfalls
- (2008) Véronique Baud et al. NATURE REVIEWS DRUG DISCOVERY
- Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma
- (2008) G. Lenz et al. SCIENCE
- Marine natural products as targeted modulators of the transcription factor NF-κB
- (2007) Florence Folmer et al. BIOCHEMICAL PHARMACOLOGY
- Differential regulation of IKKα-mediated activation of IRF3/7 by NIK
- (2007) Rui-Peng Wang et al. MOLECULAR IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search